Journal
PAEDIATRIC RESPIRATORY REVIEWS
Volume 11, Issue 2, Pages 108-114Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.prrv.2009.12.003
Keywords
macrolides; cystic fibrosis; inflammation; azithromycin
Categories
Ask authors/readers for more resources
Interest in azithromycin in the management of patients with cystic fibrosis has grown over the last decade. Uniquely this drug has both antibacterial and immune modulating effects which appear to be the reason for its clinical benefit as proven in several well designed clinical studies. In this review we discuss the proposed mechanisms of action of azithromycin and review the evidence for its clinical effectiveness and safety in cystic fibrosis. (C) 2009 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
